100% of doctors who took the live version said
they would recommend this course to their colleagues.
The FSHD Society’s highly rated CME-accredited masterclass on facioscapulohumeral muscular dystrophy (FSHD) is now available on-demand. Although FSHD is one of the most common forms of muscular dystrophy, it is often misdiagnosed and inadequately managed. This masterclass aims to shorten the diagnostic journey (currently averaging 9 years) and improve care so that patients can live well, participate in clinical trials, and fully benefit from future treatments.
This course is of interest to any physician and allied health professional who sees adult and pediatric neuromuscular patients. Those who complete the course can earn up to 4.25 AMA PRA Category 1 Credits, which are accepted by medical licensing boards in the US and Europe. If you are outside the US or EU, please check whether your local medical licensing board accepts these credits.
Please forward this information to anyone who might be interested.
CLICK HERE TO VIEW THE AGENDA AND REGISTER
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of PeerPoint Medical Education Institute and the FHSD Society.
PeerPoint Medical Education Institute is accredited by the ACCME to provide continuing medical education for physicians. PeerPoint Medical Education Institute designates the live format for this educational activity for a maximum of 4.25 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
Interest in physician education. I have 2 patients now with FSHD.